Ramsfjell V, Borge O J, Cui L, Jacobsen S E
Hipple Cancer Research Center, Dayton, OH 45439, USA.
J Immunol. 1997 Jun 1;158(11):5169-77.
Thrombopoietin (Tpo) is a primary regulator of megakaryocyte and platelet production. However, studies in c-mpl-deficient mice suggest that Tpo might also play an important role in early hemopoiesis. Here, the direct ability of Tpo to stimulate stroma-independent growth, multilineage differentiation, and progenitor cell expansion from single primitive CD34+ CD38- human bone marrow cells was investigated. Tpo alone stimulated limited clonal growth, but synergized with c-kit ligand (KL), flt3 ligand (FL), or IL-3 to potently enhance clonogenic growth. Whereas KL and FL in combination stimulated the clonal growth of only 3% of CD34+ CD38- cells, 40% of CD34+ CD38- cells were recruited by KL+FL+Tpo, demonstrating that Tpo promotes the growth of a high fraction of CD34+ CD38- progenitor cells. Additional cytokines (IL-3, IL-6, and erythropoietin (Epo)) did not significantly enhance clonal growth above that observed in response to KL+FL+Tpo. In contrast, Tpo enhanced clonogenic growth in response to KL+FL+IL-3+IL-6+Epo by as much as 80%, implicating a key role for this cytokine in early hemopoiesis. Importantly, we also demonstrate that the majority of Tpo-recruited CD34+ CD38- progenitor cells have a multilineage differentiation potential, and that Tpo promotes prolonged expansion of multipotent progenitors. Specifically, whereas progenitor cells were reduced in cultures containing only KL+FL, addition of Tpo resulted in 40-fold expansion of multipotent progenitors following a 14-day incubation. Finally, we identified inhibitors of Tpo-induced progenitor cell growth, in that TGF-beta as well as TNF-alpha almost completely abrogated the growth of CD34+ CD38- progenitor cells in response to Tpo alone as well as KL+FL+Tpo.
血小板生成素(Tpo)是巨核细胞和血小板生成的主要调节因子。然而,对c-mpl缺陷小鼠的研究表明,Tpo在早期造血过程中可能也发挥着重要作用。在此,研究了Tpo直接刺激单个原始CD34+ CD38-人骨髓细胞进行基质非依赖性生长、多系分化和祖细胞扩增的能力。单独的Tpo刺激有限的克隆生长,但与c-kit配体(KL)、flt3配体(FL)或白细胞介素-3(IL-3)协同作用,可有效增强集落形成生长。虽然KL和FL联合仅刺激3%的CD34+ CD38-细胞克隆生长,但KL+FL+Tpo可募集40%的CD34+ CD38-细胞,表明Tpo可促进大部分CD34+ CD38-祖细胞的生长。其他细胞因子(IL-3、IL-6和促红细胞生成素(Epo))并未显著增强高于KL+FL+Tpo反应所观察到的克隆生长。相反,Tpo可使KL+FL+IL-3+IL-6+Epo反应的集落形成生长增强多达80%,表明该细胞因子在早期造血中起关键作用。重要的是,我们还证明,大多数Tpo募集的CD34+ CD38-祖细胞具有多系分化潜能,且Tpo可促进多能祖细胞的长期扩增。具体而言,仅含KL+FL的培养物中祖细胞减少,添加Tpo后,经过14天孵育,多能祖细胞可扩增40倍。最后,我们鉴定出Tpo诱导的祖细胞生长抑制剂,即转化生长因子-β(TGF-β)以及肿瘤坏死因子-α(TNF-α)几乎完全消除了单独Tpo以及KL+FL+Tpo刺激下CD34+ CD38-祖细胞的生长。